Wockhardt Limited

NSE:WOCKPHARMA India Drug Manufacturers - Specialty & Generic
Market Cap
$2.23 Billion
₹193.15 Billion INR
Market Cap Rank
#7129 Global
#259 in India
Share Price
₹1188.70
Change (1 day)
-8.46%
52-Week Range
₹1188.70 - ₹1831.10
All Time High
₹1831.10
About

Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products. The company also develops its flagship antibiotic, ZAYNICH… Read more

Wockhardt Limited (WOCKPHARMA) - Total Liabilities

Latest total liabilities as of June 2025: ₹-46.57 Billion INR

Based on the latest financial reports, Wockhardt Limited (WOCKPHARMA) has total liabilities worth ₹-46.57 Billion INR as of June 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Wockhardt Limited - Total Liabilities Trend (2005–2025)

This chart illustrates how Wockhardt Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Wockhardt Limited Competitors by Total Liabilities

The table below lists competitors of Wockhardt Limited ranked by their total liabilities.

Liability Composition Analysis (2005–2025)

This chart breaks down Wockhardt Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio N/A Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -1.00 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets N/A Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Wockhardt Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Wockhardt Limited (2005–2025)

The table below shows the annual total liabilities of Wockhardt Limited from 2005 to 2025.

Year Total Liabilities Change
2025-03-31 ₹34.78 Billion -12.77%
2024-03-31 ₹39.87 Billion -0.85%
2023-03-31 ₹40.21 Billion -0.49%
2022-03-31 ₹40.41 Billion +0.71%
2021-03-31 ₹40.12 Billion -21.65%
2020-03-31 ₹51.21 Billion +6.11%
2019-03-31 ₹48.26 Billion -2.77%
2018-03-31 ₹49.64 Billion -5.45%
2017-03-31 ₹52.50 Billion +45.46%
2016-03-31 ₹36.09 Billion +17.20%
2015-03-31 ₹30.80 Billion +6.03%
2014-03-31 ₹29.04 Billion -12.93%
2013-03-31 ₹33.36 Billion -30.25%
2012-03-31 ₹47.83 Billion +0.43%
2011-03-31 ₹47.62 Billion -2.62%
2010-03-31 ₹48.90 Billion -14.36%
2009-03-31 ₹57.10 Billion +47.19%
2008-03-31 ₹38.80 Billion +46.51%
2007-03-31 ₹26.48 Billion +98.67%
2006-03-31 ₹13.33 Billion +2.35%
2005-03-31 ₹13.02 Billion --